Katarina Šurlan Popović
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Katarina Šurlan Popović has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Matija Zupan
Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia
2 shared publications - Sotirios Bisdas
Department of Translational Neuroscience and Stroke, UCL Queen Square Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK
2 shared publications - Ajda Lisec
Clinical Department of Anesthesiology and Surgical Intensive Care University Medical Center Ljubljana Ljubljana Slovenia
1 shared publication - Alja Longo
Institute of Radiology, University Medical Centre Ljubljana, Ljubljana, Slovenia
1 shared publication - Amy F. Juliano
Harvard Medical School
1 shared publication - Ana Trebše
Department of Vascular Neurology, University Medical Center, Ljubljana, Slovenia
1 shared publication
Latest Publications
- 11 November 2026
- Published by Springer Nature
- p. 1-16
Extra-cranial Vascular Malformations
- Open Access
- 22 May 2026
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 17, 307
Angioedema as anaphylactic reaction following tenecteplase administration in acute ischemic stroke: A case report
Background: Tenecteplase (TNK) is a novel thrombolytic agent with improved fibrin specificity and longer half-life than alteplase. It is increasingly being adopted worldwide for the treatment of acute ischemic stroke (AIS). Although well tolerated, rare adverse reactions can occur, such as angioedema, which can rapidly progress and potentially cause airway compromise. Case Description: We report a 60-year-old female presenting to the neurology emergency department with acute right-sided hemiplegia and motor aphasia who received intravenous TNK approximately 2 h after symptom onset. Shortly after admission, she developed progressive oropharyngeal angioedema accompanied by urticaria and inspiratory stridor. Given the risk of impending airway obstruction, she required urgent airway management with endotracheal intubation and initiation of mechanical ventilation. After stabilization, she underwent subsequent mechanical thrombectomy and carotid stenting, which were successful. Conclusion: Early recognition of thrombolytic-associated angioedema and immediate involvement of a multidisciplinary team are critical for airway protection and continuation of reperfusion therapies, helping to optimize clinical outcomes in AIS.
- 22 May 2026
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 17, 307
Open AccessAngioedema as anaphylactic reaction following tenecteplase administration in acute ischemic stroke: A case report
Background: Tenecteplase (TNK) is a novel thrombolytic agent with improved fibrin specificity and longer half-life than alteplase. It is increasingly being adopted worldwide for the treatment of acute ischemic stroke (AIS). Although well tolerated, rare adverse reactions can occur, such as angioedema, which can rapidly progress and potentially cause airway compromise. Case Description: We report a 60-year-old female presenting to the neurology emergency department with acute right-sided hemiplegia and motor aphasia who received intravenous TNK approximately 2 h after symptom onset. Shortly after admission, she developed progressive oropharyngeal angioedema accompanied by urticaria and inspiratory stridor. Given the risk of impending airway obstruction, she required urgent airway management with endotracheal intubation and initiation of mechanical ventilation. After stabilization, she underwent subsequent mechanical thrombectomy and carotid stenting, which were successful. Conclusion: Early recognition of thrombolytic-associated angioedema and immediate involvement of a multidisciplinary team are critical for airway protection and continuation of reperfusion therapies, helping to optimize clinical outcomes in AIS.
- 23 April 2022
- Published by Springer Nature in Neuroradiology
- Vol. 64 (6) , 1081-1100
Guidelines for magnetic resonance imaging in pediatric head and neck pathologies: a multicentre international consensus paper
The use of standardized imaging protocols is paramount in order to facilitate comparable, reproducible images and, consequently, to optimize patient care. Standardized MR protocols are lacking when studying head and neck pathologies in the pediatric population. We propose an international, multicenter consensus paper focused on providing the best combination of acquisition time/technical requirements and image quality. Distinct protocols for different regions of the head and neck and, in some cases, for specific pathologies or clinical indications are recommended. This white paper is endorsed by several international scientific societies and it is the result of discussion, in consensus, among experts in pediatric head and neck imaging.
- 23 April 2022
- Published by Springer Nature in Neuroradiology
- Vol. 64 (6) , 1081-1100
Guidelines for magnetic resonance imaging in pediatric head and neck pathologies: a multicentre international consensus paper
The use of standardized imaging protocols is paramount in order to facilitate comparable, reproducible images and, consequently, to optimize patient care. Standardized MR protocols are lacking when studying head and neck pathologies in the pediatric population. We propose an international, multicenter consensus paper focused on providing the best combination of acquisition time/technical requirements and image quality. Distinct protocols for different regions of the head and neck and, in some cases, for specific pathologies or clinical indications are recommended. This white paper is endorsed by several international scientific societies and it is the result of discussion, in consensus, among experts in pediatric head and neck imaging.
- Open Access
- 26 September 2021
- Published by Morressier GmbH
The role of Bayesian estimation algorithm in predicting the molecular status of gliomas using preoperative dynamic susceptibility contrast perfusion imaging
Introduction Dynamic susceptibility contrast (DSC)-MRI is a promising tool in preoperative assessment of gliomas with leakage corrected rCBV values typically considered a useful predictor of the isocitrate dehydrogenase (IDH) mutation status. Recently, a new fully adaptive and delay-insensitive Bayesian estimation of perfusion parameters was developed, outperforming the
- 26 September 2021
- Published by Morressier GmbH
Open AccessThe role of Bayesian estimation algorithm in predicting the molecular status of gliomas using preoperative dynamic susceptibility contrast perfusion imaging
Introduction Dynamic susceptibility contrast (DSC)-MRI is a promising tool in preoperative assessment of gliomas with leakage corrected rCBV values typically considered a useful predictor of the isocitrate dehydrogenase (IDH) mutation status. Recently, a new fully adaptive and delay-insensitive Bayesian estimation of perfusion parameters was developed, outperforming the
- Open Access
Multicenter DSC–MRI-Based Radiomics Predict IDH Mutation in Gliomas
To address the current lack of dynamic susceptibility contrast magnetic resonance imaging (DSC–MRI)-based radiomics to predict isocitrate dehydrogenase (IDH) mutations in gliomas, we present a multicenter study that featured an independent exploratory set for radiomics model development and external validation using two independent cohorts. The maximum performance of the IDH mutation status prediction on the validation set had an accuracy of 0.544 (Cohen’s kappa: 0.145, F1-score: 0.415, area under the curve-AUC: 0.639, sensitivity: 0.733, specificity: 0.491), which significantly improved to an accuracy of 0.706 (Cohen’s kappa: 0.282, F1-score: 0.474, AUC: 0.667, sensitivity: 0.6, specificity: 0.736) when dynamic-based standardization of the images was performed prior to the radiomics. Model explainability using local interpretable model-agnostic explanations (LIME) and Shapley additive explanations (SHAP) revealed potential intuitive correlations between the IDH–wildtype increased heterogeneity and the texture complexity. These results strengthened our hypothesis that DSC–MRI radiogenomics in gliomas hold the potential to provide increased predictive performance from models that generalize well and provide understandable patterns between IDH mutation status and the extracted features toward enabling the clinical translation of radiogenomics in neuro-oncology.
Open AccessMulticenter DSC–MRI-Based Radiomics Predict IDH Mutation in Gliomas
To address the current lack of dynamic susceptibility contrast magnetic resonance imaging (DSC–MRI)-based radiomics to predict isocitrate dehydrogenase (IDH) mutations in gliomas, we present a multicenter study that featured an independent exploratory set for radiomics model development and external validation using two independent cohorts. The maximum performance of the IDH mutation status prediction on the validation set had an accuracy of 0.544 (Cohen’s kappa: 0.145, F1-score: 0.415, area under the curve-AUC: 0.639, sensitivity: 0.733, specificity: 0.491), which significantly improved to an accuracy of 0.706 (Cohen’s kappa: 0.282, F1-score: 0.474, AUC: 0.667, sensitivity: 0.6, specificity: 0.736) when dynamic-based standardization of the images was performed prior to the radiomics. Model explainability using local interpretable model-agnostic explanations (LIME) and Shapley additive explanations (SHAP) revealed potential intuitive correlations between the IDH–wildtype increased heterogeneity and the texture complexity. These results strengthened our hypothesis that DSC–MRI radiogenomics in gliomas hold the potential to provide increased predictive performance from models that generalize well and provide understandable patterns between IDH mutation status and the extracted features toward enabling the clinical translation of radiogenomics in neuro-oncology.
- Open Access
- 2 September 2015
- Published by Springer Nature in BMC Neurology
- Vol. 15 (1) , 158
The presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis - a case control pilot study
In spite of high prevalence and clinical relevance of leukoaraiosis (LA), its pathophysiology is still incompletely understood. Theories of ischaemic genesis and a leaky blood–brain barrier are contradictory yet could share a common denominator–endothelial dysfunction (cerebral, systemic or both), which has not been studied thoroughly in LA. Thirty patients with LA (58 years (SD 7)) and 30 gender- and age-matched controls without LA (55 years (SD 6)) were recruited. The vascular risk factors (VRF) were identical in both groups. Cerebral endothelial function was determined by cerebrovascular reactivity to L-arginine (CVR). Systemic endothelial function was determined by flow-mediated dilatation (FMD) of the brachial artery after hyperaemia. All participants underwent a brain MRI to search for radiological signs of LA that was classified according to the Fazekas score. Linear regression was used to explore the correlation between CVR and FMD in patients with LA. A 95 % confidence interval was used. For any statistical test used in the study, p ≤ 0.050 was regarded as statistically significant. We found a marked and significant decrease in both CVR (9.6 % (SD 3.2) vs. 15.8 % (SD 6.1), p < 0.001) and FMD (4.8 % (SD 3.1) vs. 7.4 % (SD 3.8), p = 0.004) in LA patients compared to controls. Both CVR (7.4 % (SD 3.1) vs. 12.2 % (SD 2.6), p = 0.001) and FMD (3.0 % (SD 2.2) vs. 6.4 % (SD 3.1), p = 0.011) were significantly decreased in LA subgroup Fazekas 3 compared to subgroup Fazekas 1. CVR and FMD significantly positively correlated (b = 0.192, 95 % CI = 0.031–0.354, p = 0.02). The results of our pilot study suggest that patients with LA have a significant impairment of both cerebral and systemic endothelial function that is larger than could be expected based on present VRF. Endothelial dysfunction increases in parallel with LA severity and correlates between cerebral and systemic arterial territory. Overall, our results suggest a so far unknown “intrinsic” generalised endothelial dysfunction in patients with LA that could be involved in LA pathophysiology. This interesting issue needs to be confirmed in larger samples since it could help better understand the mechanisms underlying LA.
- 2 September 2015
- Published by Springer Nature in BMC Neurology
- Vol. 15 (1) , 158
Open AccessThe presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis - a case control pilot study
In spite of high prevalence and clinical relevance of leukoaraiosis (LA), its pathophysiology is still incompletely understood. Theories of ischaemic genesis and a leaky blood–brain barrier are contradictory yet could share a common denominator–endothelial dysfunction (cerebral, systemic or both), which has not been studied thoroughly in LA. Thirty patients with LA (58 years (SD 7)) and 30 gender- and age-matched controls without LA (55 years (SD 6)) were recruited. The vascular risk factors (VRF) were identical in both groups. Cerebral endothelial function was determined by cerebrovascular reactivity to L-arginine (CVR). Systemic endothelial function was determined by flow-mediated dilatation (FMD) of the brachial artery after hyperaemia. All participants underwent a brain MRI to search for radiological signs of LA that was classified according to the Fazekas score. Linear regression was used to explore the correlation between CVR and FMD in patients with LA. A 95 % confidence interval was used. For any statistical test used in the study, p ≤ 0.050 was regarded as statistically significant. We found a marked and significant decrease in both CVR (9.6 % (SD 3.2) vs. 15.8 % (SD 6.1), p < 0.001) and FMD (4.8 % (SD 3.1) vs. 7.4 % (SD 3.8), p = 0.004) in LA patients compared to controls. Both CVR (7.4 % (SD 3.1) vs. 12.2 % (SD 2.6), p = 0.001) and FMD (3.0 % (SD 2.2) vs. 6.4 % (SD 3.1), p = 0.011) were significantly decreased in LA subgroup Fazekas 3 compared to subgroup Fazekas 1. CVR and FMD significantly positively correlated (b = 0.192, 95 % CI = 0.031–0.354, p = 0.02). The results of our pilot study suggest that patients with LA have a significant impairment of both cerebral and systemic endothelial function that is larger than could be expected based on present VRF. Endothelial dysfunction increases in parallel with LA severity and correlates between cerebral and systemic arterial territory. Overall, our results suggest a so far unknown “intrinsic” generalised endothelial dysfunction in patients with LA that could be involved in LA pathophysiology. This interesting issue needs to be confirmed in larger samples since it could help better understand the mechanisms underlying LA.